HAMBURG, Germany, January 29, 2024 / B3C newswire / FUSE-AI GmbH, an innovator in artificial intelligence for radiology, today announced its AI software "Prostate.Carcinoma.ai" has received EU Medical Device Regulation (MDR) 2017/745 IIa certification. As of January 2024, the company is authorized to distribute i.